0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Solid Organ Transplantation Rejection (SOT) Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-11P17520
Home | Market Reports | Health| Nursing
Global Solid Organ Transplantation Rejection SOT Market Research Report 2024
BUY CHAPTERS

Global Solid Organ Transplantation Rejection (SOT) Market Research Report 2024

Code: QYRE-Auto-11P17520
Report
May 2024
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Solid Organ Transplantation Rejection (SOT) Market

The global Solid Organ Transplantation Rejection (SOT) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Solid Organ Transplantation Rejection (SOT) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Solid Organ Transplantation Rejection (SOT) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Solid Organ Transplantation Rejection (SOT) in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Solid Organ Transplantation Rejection (SOT) include Novartis, Terumo, Roche, Astellas Pharma, Preservation Solutions, Transmedic, Pfizer, Sanofi, Veloxis Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Solid Organ Transplantation Rejection (SOT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Organ Transplantation Rejection (SOT).
The Solid Organ Transplantation Rejection (SOT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solid Organ Transplantation Rejection (SOT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Organ Transplantation Rejection (SOT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Solid Organ Transplantation Rejection (SOT) Market Report

Report Metric Details
Report Name Solid Organ Transplantation Rejection (SOT) Market
Segment by Type
  • Kidney
  • Heart
  • Liver
Segment by Application
  • Hospital
  • Transplant Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Terumo, Roche, Astellas Pharma, Preservation Solutions, Transmedic, Pfizer, Sanofi, Veloxis Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Solid Organ Transplantation Rejection (SOT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Solid Organ Transplantation Rejection (SOT) Market report?

Ans: The main players in the Solid Organ Transplantation Rejection (SOT) Market are Novartis, Terumo, Roche, Astellas Pharma, Preservation Solutions, Transmedic, Pfizer, Sanofi, Veloxis Pharmaceuticals

What are the Application segmentation covered in the Solid Organ Transplantation Rejection (SOT) Market report?

Ans: The Applications covered in the Solid Organ Transplantation Rejection (SOT) Market report are Hospital, Transplant Centers, Others

What are the Type segmentation covered in the Solid Organ Transplantation Rejection (SOT) Market report?

Ans: The Types covered in the Solid Organ Transplantation Rejection (SOT) Market report are Kidney, Heart, Liver

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kidney
1.2.3 Heart
1.2.4 Liver
1.3 Market by Application
1.3.1 Global Solid Organ Transplantation Rejection (SOT) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Transplant Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid Organ Transplantation Rejection (SOT) Market Perspective (2019-2030)
2.2 Global Solid Organ Transplantation Rejection (SOT) Growth Trends by Region
2.2.1 Global Solid Organ Transplantation Rejection (SOT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Solid Organ Transplantation Rejection (SOT) Historic Market Size by Region (2019-2024)
2.2.3 Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Region (2025-2030)
2.3 Solid Organ Transplantation Rejection (SOT) Market Dynamics
2.3.1 Solid Organ Transplantation Rejection (SOT) Industry Trends
2.3.2 Solid Organ Transplantation Rejection (SOT) Market Drivers
2.3.3 Solid Organ Transplantation Rejection (SOT) Market Challenges
2.3.4 Solid Organ Transplantation Rejection (SOT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid Organ Transplantation Rejection (SOT) Players by Revenue
3.1.1 Global Top Solid Organ Transplantation Rejection (SOT) Players by Revenue (2019-2024)
3.1.2 Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Players (2019-2024)
3.2 Global Solid Organ Transplantation Rejection (SOT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Solid Organ Transplantation Rejection (SOT) Revenue
3.4 Global Solid Organ Transplantation Rejection (SOT) Market Concentration Ratio
3.4.1 Global Solid Organ Transplantation Rejection (SOT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Organ Transplantation Rejection (SOT) Revenue in 2023
3.5 Global Key Players of Solid Organ Transplantation Rejection (SOT) Head office and Area Served
3.6 Global Key Players of Solid Organ Transplantation Rejection (SOT), Product and Application
3.7 Global Key Players of Solid Organ Transplantation Rejection (SOT), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid Organ Transplantation Rejection (SOT) Breakdown Data by Type
4.1 Global Solid Organ Transplantation Rejection (SOT) Historic Market Size by Type (2019-2024)
4.2 Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Type (2025-2030)
5 Solid Organ Transplantation Rejection (SOT) Breakdown Data by Application
5.1 Global Solid Organ Transplantation Rejection (SOT) Historic Market Size by Application (2019-2024)
5.2 Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Solid Organ Transplantation Rejection (SOT) Market Size (2019-2030)
6.2 North America Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2019-2024)
6.4 North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid Organ Transplantation Rejection (SOT) Market Size (2019-2030)
7.2 Europe Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2019-2024)
7.4 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size (2019-2030)
8.2 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2019-2024)
8.4 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid Organ Transplantation Rejection (SOT) Market Size (2019-2030)
9.2 Latin America Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2019-2024)
9.4 Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size (2019-2030)
10.2 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2019-2024)
10.4 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Solid Organ Transplantation Rejection (SOT) Introduction
11.1.4 Novartis Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Terumo
11.2.1 Terumo Company Details
11.2.2 Terumo Business Overview
11.2.3 Terumo Solid Organ Transplantation Rejection (SOT) Introduction
11.2.4 Terumo Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
11.2.5 Terumo Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Solid Organ Transplantation Rejection (SOT) Introduction
11.3.4 Roche Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Solid Organ Transplantation Rejection (SOT) Introduction
11.4.4 Astellas Pharma Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
11.4.5 Astellas Pharma Recent Development
11.5 Preservation Solutions
11.5.1 Preservation Solutions Company Details
11.5.2 Preservation Solutions Business Overview
11.5.3 Preservation Solutions Solid Organ Transplantation Rejection (SOT) Introduction
11.5.4 Preservation Solutions Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
11.5.5 Preservation Solutions Recent Development
11.6 Transmedic
11.6.1 Transmedic Company Details
11.6.2 Transmedic Business Overview
11.6.3 Transmedic Solid Organ Transplantation Rejection (SOT) Introduction
11.6.4 Transmedic Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
11.6.5 Transmedic Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Solid Organ Transplantation Rejection (SOT) Introduction
11.7.4 Pfizer Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Solid Organ Transplantation Rejection (SOT) Introduction
11.8.4 Sanofi Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Veloxis Pharmaceuticals
11.9.1 Veloxis Pharmaceuticals Company Details
11.9.2 Veloxis Pharmaceuticals Business Overview
11.9.3 Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Introduction
11.9.4 Veloxis Pharmaceuticals Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
11.9.5 Veloxis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Kidney
 Table 3. Key Players of Heart
 Table 4. Key Players of Liver
 Table 5. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Solid Organ Transplantation Rejection (SOT) Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region (2019-2024)
 Table 9. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region (2025-2030)
 Table 11. Solid Organ Transplantation Rejection (SOT) Market Trends
 Table 12. Solid Organ Transplantation Rejection (SOT) Market Drivers
 Table 13. Solid Organ Transplantation Rejection (SOT) Market Challenges
 Table 14. Solid Organ Transplantation Rejection (SOT) Market Restraints
 Table 15. Global Solid Organ Transplantation Rejection (SOT) Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Solid Organ Transplantation Rejection (SOT) Market Share by Players (2019-2024)
 Table 17. Global Top Solid Organ Transplantation Rejection (SOT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Organ Transplantation Rejection (SOT) as of 2023)
 Table 18. Ranking of Global Top Solid Organ Transplantation Rejection (SOT) Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Solid Organ Transplantation Rejection (SOT) Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Solid Organ Transplantation Rejection (SOT), Headquarters and Area Served
 Table 21. Global Key Players of Solid Organ Transplantation Rejection (SOT), Product and Application
 Table 22. Global Key Players of Solid Organ Transplantation Rejection (SOT), Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Solid Organ Transplantation Rejection (SOT) Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Type (2019-2024)
 Table 26. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Type (2025-2030)
 Table 28. Global Solid Organ Transplantation Rejection (SOT) Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Application (2019-2024)
 Table 30. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Application (2025-2030)
 Table 32. North America Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Novartis Company Details
 Table 48. Novartis Business Overview
 Table 49. Novartis Solid Organ Transplantation Rejection (SOT) Product
 Table 50. Novartis Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024) & (US$ Million)
 Table 51. Novartis Recent Development
 Table 52. Terumo Company Details
 Table 53. Terumo Business Overview
 Table 54. Terumo Solid Organ Transplantation Rejection (SOT) Product
 Table 55. Terumo Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024) & (US$ Million)
 Table 56. Terumo Recent Development
 Table 57. Roche Company Details
 Table 58. Roche Business Overview
 Table 59. Roche Solid Organ Transplantation Rejection (SOT) Product
 Table 60. Roche Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024) & (US$ Million)
 Table 61. Roche Recent Development
 Table 62. Astellas Pharma Company Details
 Table 63. Astellas Pharma Business Overview
 Table 64. Astellas Pharma Solid Organ Transplantation Rejection (SOT) Product
 Table 65. Astellas Pharma Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024) & (US$ Million)
 Table 66. Astellas Pharma Recent Development
 Table 67. Preservation Solutions Company Details
 Table 68. Preservation Solutions Business Overview
 Table 69. Preservation Solutions Solid Organ Transplantation Rejection (SOT) Product
 Table 70. Preservation Solutions Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024) & (US$ Million)
 Table 71. Preservation Solutions Recent Development
 Table 72. Transmedic Company Details
 Table 73. Transmedic Business Overview
 Table 74. Transmedic Solid Organ Transplantation Rejection (SOT) Product
 Table 75. Transmedic Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024) & (US$ Million)
 Table 76. Transmedic Recent Development
 Table 77. Pfizer Company Details
 Table 78. Pfizer Business Overview
 Table 79. Pfizer Solid Organ Transplantation Rejection (SOT) Product
 Table 80. Pfizer Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024) & (US$ Million)
 Table 81. Pfizer Recent Development
 Table 82. Sanofi Company Details
 Table 83. Sanofi Business Overview
 Table 84. Sanofi Solid Organ Transplantation Rejection (SOT) Product
 Table 85. Sanofi Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024) & (US$ Million)
 Table 86. Sanofi Recent Development
 Table 87. Veloxis Pharmaceuticals Company Details
 Table 88. Veloxis Pharmaceuticals Business Overview
 Table 89. Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Product
 Table 90. Veloxis Pharmaceuticals Revenue in Solid Organ Transplantation Rejection (SOT) Business (2019-2024) & (US$ Million)
 Table 91. Veloxis Pharmaceuticals Recent Development
 Table 92. Research Programs/Design for This Report
 Table 93. Key Data Information from Secondary Sources
 Table 94. Key Data Information from Primary Sources
 Table 95. Authors List of This Report


List of Figures
 Figure 1. Solid Organ Transplantation Rejection (SOT) Picture
 Figure 2. Global Solid Organ Transplantation Rejection (SOT) Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Solid Organ Transplantation Rejection (SOT) Market Share by Type: 2023 VS 2030
 Figure 4. Kidney Features
 Figure 5. Heart Features
 Figure 6. Liver Features
 Figure 7. Global Solid Organ Transplantation Rejection (SOT) Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Solid Organ Transplantation Rejection (SOT) Market Share by Application: 2023 VS 2030
 Figure 9. Hospital Case Studies
 Figure 10. Transplant Centers Case Studies
 Figure 11. Others Case Studies
 Figure 12. Solid Organ Transplantation Rejection (SOT) Report Years Considered
 Figure 13. Global Solid Organ Transplantation Rejection (SOT) Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Solid Organ Transplantation Rejection (SOT) Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region: 2023 VS 2030
 Figure 16. Global Solid Organ Transplantation Rejection (SOT) Market Share by Players in 2023
 Figure 17. Global Top Solid Organ Transplantation Rejection (SOT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Organ Transplantation Rejection (SOT) as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Solid Organ Transplantation Rejection (SOT) Revenue in 2023
 Figure 19. North America Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Solid Organ Transplantation Rejection (SOT) Market Share by Country (2019-2030)
 Figure 21. United States Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Solid Organ Transplantation Rejection (SOT) Market Share by Country (2019-2030)
 Figure 25. Germany Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Share by Region (2019-2030)
 Figure 33. China Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Solid Organ Transplantation Rejection (SOT) Market Share by Country (2019-2030)
 Figure 41. Mexico Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Share by Country (2019-2030)
 Figure 45. Turkey Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Novartis Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
 Figure 49. Terumo Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
 Figure 50. Roche Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
 Figure 51. Astellas Pharma Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
 Figure 52. Preservation Solutions Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
 Figure 53. Transmedic Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
 Figure 54. Pfizer Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
 Figure 55. Sanofi Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
 Figure 56. Veloxis Pharmaceuticals Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2019-2024)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart